Enhancing IP Protection in Biotechnology with Barcoded Version-Controlled Cells
Intellectual property (IP) protection and traceability in biotechnology present ongoing challenges, particularly for genetically modified organisms (GMOs) and proprietary cell lines. Our latest white paper, developed in collaboration with Potter Clarkson, explores how barcoded version-controlled cells can provide a structured approach to addressing these challenges. Our solutions—CellRepo® and GenoSignature™—offer a way to enhance provenance tracking, […]
GitLife Biotech and Colorifix Partner to Research Scalable, Traceable, and Sustainable Dyeing Processes
GitLife Biotech has partnered with Colorifix, a leading innovator in sustainable dye production, to enhance traceability and scalability in eco-friendly textile dyeing. Supported by Innovate UK, this collaboration investigates integrating advanced genetic barcoding into Colorifix’s dye manufacturing processes, enabling secure and efficient deployment of sustainable practices in the textile industry. Revolutionising Dye Manufacturing with Nature […]
Gitlife Biotech Appoints Beatrix Ellis as CEO
GitLife Biotech Ltd., is pleased to announce the appointment of Beatrix Ellis as its new Chief Executive Officer. Beatrix Ellis brings extensive experience in commercial strategy and a proven record in business development and capital raising, making her a strong fit to guide GitLife’s next phase of growth. She will oversee the company’s initiatives to […]
GitLife Biotech and NCIMB Secure Innovate UK Funding to Advance Synthetic Biology Therapeutics
GitLife Biotech is excited to announce the receipt of Innovate UK funding for the development of groundbreaking therapeutic solutions, in collaboration with NCIMB Ltd. This partnership aims to leverage synthetic biology and live bacteria to create new health-enhancing treatments. Innovate UK Funding Boost The Innovate UK grant supports a 12-month project focused on using GitLife’s […]
